Detalhe da pesquisa
1.
Magnetic resonance imaging as a predictor of therapeutic response to pasireotide in acromegaly.
Clin Endocrinol (Oxf)
; 99(4): 378-385, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37421211
2.
Quality of life impairment after a diagnosis of Cushing's syndrome.
Pituitary
; 25(5): 768-771, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767164
3.
Prevalence of sarcopenia after remission of hypercortisolism and its impact on HRQoL.
Clin Endocrinol (Oxf)
; 95(5): 735-743, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34323296
4.
Molecular determinants of enhanced response to somatostatin receptor ligands after debulking in large GH-producing adenomas.
Clin Endocrinol (Oxf)
; 94(5): 811-819, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32978826
5.
Patient-Centered Outcomes with Pituitary and Parasellar Disease.
Neuroendocrinology
; 110(9-10): 882-888, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101858
6.
Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.
Clin Endocrinol (Oxf)
; 88(6): 787-798, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29574994
7.
A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome.
Clin Endocrinol (Oxf)
; 87(5): 433-439, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28665508
8.
Cystatin-C and epicardial adipose tissue as noninvasive predictors of cardiovascular risk in acromegaly.
Clin Endocrinol (Oxf)
; 86(2): 214-222, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27910111
9.
Update on quality of life in patients with acromegaly.
Pituitary
; 20(1): 185-188, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27730455
10.
Quality of life in Cushing's syndrome.
Pituitary
; 18(2): 195-200, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25647329
11.
Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome.
Clin Endocrinol (Oxf)
; 81(6): 826-33, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25052342
12.
Cushing's syndrome in the elderly.
Exp Clin Endocrinol Diabetes
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38698635
13.
New molecular tools for precision medicine in pituitary neuroendocrine tumors.
Minerva Endocrinol (Torino)
; 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261299
14.
The thrombotic risk in Cushing's syndrome-questions, answers, and the algorithm to consider in its assessment: part I-thrombotic risk not related to surgery.
Front Endocrinol (Lausanne)
; 15: 1350010, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38529392
15.
Evaluation of bone-related mechanical properties in female patients with long-term remission of Cushing's syndrome using quantitative computed tomography-based finite element analysis.
Eur J Endocrinol
; 190(1): 86-95, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38285633
16.
High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery.
Eur J Endocrinol
; 190(1): 75-85, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38146835
17.
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study.
Eur J Endocrinol
; 190(6): 421-433, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701338
18.
Gut microbial dysbiosis in patients with Cushing's disease in long-term remission. Relationship with cardiometabolic risk.
Front Endocrinol (Lausanne)
; 14: 1074757, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37342265
19.
Cushing's syndrome in the elderly: data from the European Registry on Cushing's syndrome.
Eur J Endocrinol
; 188(4): 395-406, 2023 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36749009
20.
Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors.
Front Endocrinol (Lausanne)
; 14: 1129213, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37033229